Patient
SITE008-0142
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE008 (KOR) (Dr. Kim)
consented 2026-02-09
Adverse events
4
Serious AEs
1
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 4
Grade 3 Vomiting — outcome: RECOVERED/RESOLVED; onset 2022-12-03 (study day 102); relationship: NOT RELATED; serious criteria: hospitalization
Grade 1 Anaemia — outcome: UNKNOWN; onset 2022-11-20 (study day 89); relationship: not assessed
Grade 2 Stomatitis — outcome: RECOVERED/RESOLVED; onset 2022-11-12 (study day 81); relationship: NOT RELATED
Grade 1 Decreased appetite — outcome: RECOVERED/RESOLVED; onset 2022-10-16 (study day 54); relationship: RELATED
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.